Medicofarma Biotech Spolka Akcyjna
MDB | WAR
Overview
Corporate Details
- ISIN(s):
- PLINBOK00010
- LEI:
- 259400W39H7UHW9EJP66
- Country:
- Poland
- Address:
- Warszawa Sokołowska 9/U19, 01-142 Warszawa
- Website:
- http://medicofarmabiotech.pl
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Medicofarma Biotech Spolka Akcyjna is a publicly-traded company dedicated to the development of innovative pharmaceuticals, medical products, and biotechnological solutions. Our mission is to create groundbreaking medications that enhance the prevention and treatment of modern diseases. We leverage cutting-edge technology and the expertise of seasoned specialists to drive our research initiatives. Our R&D center collaborates with pharmaceutical and cosmetic companies, as well as academic institutions, to provide comprehensive support in developing generics and cosmetics. We are actively seeking new scientific, clinical, and business partnerships to further our innovative projects, including cancer therapies and adaptogenic products. As we expand, we invite potential investors to join us on this transformative journey in healthcare.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-18 18:43 |
Regulatory News Service
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
|
Polish | 1.3 KB | |
| 2024-03-06 19:35 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 3.3 KB | |
| 2024-01-03 22:51 |
Regulatory News Service
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
|
Polish | 1.7 KB | |
| 2024-01-02 17:16 |
Regulatory News Service
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
|
Polish | 4.5 KB | |
| 2023-12-31 19:41 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 2.1 KB | |
| 2023-12-31 19:33 |
Regulatory News Service
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
|
Polish | 2.9 KB | |
| 2023-12-31 19:24 |
Regulatory News Service
Strategia na lata 2024-2026
|
Polish | 2.6 MB | |
| 2023-12-31 19:24 |
Regulatory News Service
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
|
Polish | 1.8 KB | |
| 2023-10-26 22:42 |
Regulatory News Service
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
|
Polish | 2.5 KB | |
| 2023-10-23 20:42 |
Regulatory News Service
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
|
Polish | 6.3 KB | |
| 2023-10-11 21:07 |
Regulatory News Service
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
|
Polish | 1.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |